CClinicalTrials.gg
CompletedNCT02279706R-CATUpdated May 2, 2016

Korean Linguistic Adaptation of Rhinitis Controlled Assessment Test

An observational study in Rhinitis, sponsored by Ajou University School of Medicine. Completed at 1 site in Korea, Republic of. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2016-05-02.

Sponsored by Ajou University School of Medicine · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
130
Ages
19 Years and older
Sex
All
01

Study summary

Korean linguistic adaptation of Rhinitis controlled assessment test (RCAT).

Read the detailed description

Check the Korean version of rhinitis controlled assessment tests, the total non-symptom scores (total nasal symptoms score, TNSS), rhinitis-related quality of life (RQLQ), rhinitis controlled degree, severity, and after study enrollment and 4 weeks treatment.

02

Conditions studied

  • Rhinitis

Browse trials for

03

In context

Rhinitis

1,105 studies on the registry are indexed under Rhinitis; 65 are open to participants now.

This study's enrollment of 130 is close to the median of 141 across 172 observational studies indexed under Rhinitis.

Browse Rhinitis studies →

Lead sponsor

Ajou University School of Medicine is the lead sponsor of 171 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

rhinitis within 12 months from the time of study enrollment.

Inclusion criteria

  1. Adults over 19 years
  2. Past medical history and allergy skin test or who have been diagnosed with allergic or non-allergic rhinitis, based on serum specific immunoglobulin E .
  3. People who have experienced symptoms of rhinitis within 12 months from the time of study enrollment.
  4. People who have rhinitis symptoms requiring medication at the time of study enrollment.
  5. People who can read and write korea language.
  6. People who signed a written consent form approved by the Institutional Review Board of their respective organizations to participate in this study freely hearing to explain fully the purpose for the contents of this study prior to participation in research.

Exclusion criteria

Exclusion Criteria:

  1. People diagnosed with Rhinitis medicamentosa.
  2. People determined that bacterial or viral respiratory infection at the time of study enrollment.
  3. People who have evidence of nasal infection
  4. People associated anatomical abnormality that causes severe nasal congestion as deviation of nasal septum.
  5. People determined that acute or chronic sinusitis according to the researchers determined.
  6. In case that pregnancy test is positive, or ambiguous conclusions among female patients.
  7. people deemed unsuitable for clinical trial participation due to other reasons.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
130 participants (actual)
Patient registry
No

Interventions

  • Otherquestionnaire

    Check the Korean version of rhinitis controlled assessment tests, the total non-symptom scores (total nasal symptoms score, TNSS), rhinitis-related quality of life (RQLQ), rhinitis controlled degree, severity, and after study enrollment and 4 weeks treatment.

    Also known as: questionnaire(R-CAT-RQLQ)

06

What researchers measure

Primary outcomes

  1. Korean linguistic adaptation of Rhinitis controlled assessment test (RCAT)

    Check the Korean version of rhinitis controlled assessment tests

    Time frame: up to 4weeks

Secondary outcomes

  1. rhinitis-related quality of life

    rhinitis-related quality of life (RQLQ)check up to 24 weeks

    Time frame: up to 4weeks

07

Study locations

1 site
  • Ajou University Medical Center
    Suwon, Korea, Republic of
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 2, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02279706
Lead sponsor
Ajou University School of Medicine
Responsible party
Hae-Sim Park (professor, Department of allergic interal medicine, Ajou University School of Medicine) — Principal investigator
First posted
Oct 31, 2014
Start date
Oct 2014
Primary completion
Sep 2015
Completion
Oct 2015
Last update
May 2, 2016

Study contacts

hae sim park, professor
principal investigator · Department of internal medicine

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion